TLV · GEFR.TA
Geffen Residence & Renewal Ltd
₪0.75₪0.00 (0.0%)
Geffen Residence & Renewal Ltd’s quoted price sits in the lower half of its reported 52-week range, 16.55% below the high.
Loading market information…
TLV · REKA.TA · ILA
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Rekah Pharmaceutical Industry Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Rekah Pharmaceutical Industry Ltd.’s forward annual dividend is ₪0.87 per share, paid annual. The forward yield is 8.51% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Rekah Pharmaceutical Industry Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₪0.75₪0.00 (0.0%)
Geffen Residence & Renewal Ltd’s quoted price sits in the lower half of its reported 52-week range, 16.55% below the high.
₪16.03-₪0.01 (-0.06%)
G.F.C Green Fields Capital Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.96% below the high.
₪1.11₪0.00 (0.0%)
Dna Group (T.R.) Ltd’s quoted price sits in the lower half of its reported 52-week range, 26.8% below the high.
$2.54-$0.07 (-2.68%)
Enlivex Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
₪27.94₪0.00 (0.0%)
Kadimastem Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.51% below the high.
₪9.48+₪0.08 (+0.81%)
Nissan Medical Industries Ltd’s quoted price sits in the upper half of its reported 52-week range, 15.6% below the high.
₪2.56-₪0.00 (-0.12%)
Seach Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.68% below the high.
₪3.96-₪0.02 (-0.43%)
Pluri Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.42% below the high.
